Sebastian Doerck

Effects of Natalizumab Treatment on Foxp3+ T Regulatory Cells

Max‐Philipp Stenner, Anne Waschbisch, Dorothea Buck et al. · PLoS ONE · 2008 · 56 citations · Full text

Alemtuzumab as rescue therapy in a cohort of 50 relapsing–remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study

Konstantin Huhn, Antonios Bayas, Sebastian Doerck et al. · Journal of Neurology · 2018 · 35 citations

Rheumatology, Ms Patients, Clinical Trials +5

Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis

Sebastian Doerck, Kerstin Göbel, Gesa Weise et al. · PLoS ONE · 2010 · 26 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +18

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation

Steffen Pfeuffer, René Schmidt, Frederike Straeten et al. · Journal of Neurology · 2018 · 22 citations

Translational Medicine, Oncology, Clinical Therapeutic +7

Two years’ experience of implementing a comprehensive telemedical stroke network comprising in mainly rural region: the Transregional Network for Stroke Intervention with Telemedicine (TRANSIT-Stroke)

Katharina M. A. Gabriel, Steffi Jírů-Hillmann, Peter Kraft et al. · BMC Neurology · 2020 · 22 citations · Full text